16:15 EDT 10x Genomics (TXG) backs FY26 revenue view $600M-$625M, consensus $612.74M
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- 10x Genomics price target raised to $32 from $22 at Canaccord
- 10x Genomics price target raised to $30 from $21 at BofA
- 10x Genomics announces Atera, a new in situ spatial biology platform
- 10x Genomics price target raised to $30 from $22 at Barclays
- 10x Genomics price target raised to $24 from $18 at Citi